Drug Enforcement D-0183-2023

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Status

Terminated

Classification

Class I

Report Date

February 1, 2023

Termination Date

February 26, 2024

Product Information

Product description
Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5
Product quantity
209,292 capsules
Reason for recall
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide in the USA.

Location & Firm

Recalling firm
Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
Address
184 Liberty Corner Rd, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0183-2023
Event ID
91259
Recall initiation date
December 6, 2022
Center classification date
January 25, 2023
Code info
Lot: R93517, R94072, R94073, Exp 02/29/2024; T00655, Exp 03/31/2025
More code info
—